A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHL
Indiana University
Indiana University
M.D. Anderson Cancer Center
Columbia University
Abramson Cancer Center at Penn Medicine
University of Washington
University of Washington
Mayo Clinic
Mayo Clinic
OHSU Knight Cancer Institute
Icahn School of Medicine at Mount Sinai
Sunnybrook Health Sciences Centre
NYU Langone Health
Western Regional Medical Center